We are live on ! Find out more
ACM

Aster Capital Management Portfolio holdings

AUM $306M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
+$30.4M
Cap. Flow
+$30.3M
Cap. Flow %
13.29%
Top 10 Hldgs %
31.68%
Holding
1,487
New
557
Increased
199
Reduced
298
Closed
433

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.18M
2
ABT icon
Abbott
ABT
+$2.92M
3
HCA icon
HCA Healthcare
HCA
+$2.86M
4
WFC icon
Wells Fargo
WFC
+$2.72M
5
BAC icon
Bank of America
BAC
+$2.5M

Sector Composition

Rank Sector Weight
1 Technology 21.46%
2 Financials 12.13%
3 Industrials 10.93%
4 Healthcare 10.36%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNX icon
801
Cognex
CGNX
$11.8B
$7.45K ﹤0.01%
207
-298
-59% -$12.1K
SPHR icon
802
Sphere Entertainment
SPHR
$5.77B
$7.42K ﹤0.01%
78
-56
-42% -$4.27K
EFC
803
Ellington Financial
EFC
$1.66B
$7.36K ﹤0.01%
542
-396
-42% -$5.39K
UPB
804
Upstream Bio Inc
UPB
$367M
$7.36K ﹤0.01%
271
-870
-76% -$21.7K
CRNX icon
805
Crinetics Pharmaceuticals
CRNX
$8.91B
$7.36K ﹤0.01%
+158
New +$7.03K
WD icon
806
Walker & Dunlop
WD
$1.76B
$7.34K ﹤0.01%
+122
New +$8.66K
HAPN
807
Happen Inc
HAPN
$2.36B
$7.29K ﹤0.01%
385
-1,343
-78% -$23.7K
LUCK
808
Lucky Strike Entertainment
LUCK
$926M
$7.16K ﹤0.01%
845
+755
+839% +$6.52K
ALMS
809
Alumis Inc
ALMS
$3.46B
$7.11K ﹤0.01%
+728
New +$5.08K
COCO icon
810
Vita Coco
COCO
$3.75B
$7.1K ﹤0.01%
134
+92
+219% +$4.32K
BHE icon
811
Benchmark Electronics
BHE
$3.02B
$7.1K ﹤0.01%
166
-859
-84% -$37.2K
FULC icon
812
Fulcrum Therapeutics
FULC
$288M
$7.05K ﹤0.01%
+623
New +$6.34K
NUVL
813
DELISTED
Nuvalent
NUVL
$7.04K ﹤0.01%
70
-371
-84% -$36.6K
URGN icon
814
UroGen Pharma
URGN
$2.26B
$6.98K ﹤0.01%
+298
New +$6.46K
BCRX icon
815
BioCryst Pharmaceuticals
BCRX
$2.31B
$6.97K ﹤0.01%
+894
New +$6.46K
SKYW icon
816
Skywest
SKYW
$4.5B
$6.93K ﹤0.01%
69
-93
-57% -$9.31K
CUBI icon
817
Customers Bancorp
CUBI
$2.79B
$6.87K ﹤0.01%
94
-843
-90% -$57.8K
BY icon
818
Byline Bancorp
BY
$1.79B
$6.82K ﹤0.01%
+234
New +$6.57K
OPLN
819
Openlane
OPLN
$4.69B
$6.79K ﹤0.01%
228
-269
-54% -$7.28K
NVGS icon
820
Navigator Holdings
NVGS
$1.27B
$6.72K ﹤0.01%
388
-9,942
-96% -$166K
KRYS icon
821
Krystal Biotech
KRYS
$9.64B
$6.66K ﹤0.01%
+27
New +$5.68K
JOE icon
822
St. Joe Company
JOE
$3.7B
$6.53K ﹤0.01%
+110
New +$6.16K
KTOS icon
823
Kratos Defense & Security Solutions
KTOS
$10.4B
$6.53K ﹤0.01%
86
+55
+177% +$4.5K
PRLB icon
824
Protolabs
PRLB
$2.16B
$6.53K ﹤0.01%
129
-8
-6% -$409
GOSS icon
825
Gossamer Bio
GOSS
$86.9M
$6.51K ﹤0.01%
+2,100
New +$5.99K

Similar funds

Aster Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Aster Capital Management held 1,487 positions worth $228M, up 15% from $198M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Aster Capital Management deployed $30.3M of net new capital in Q4 2025, opening 557 new positions and adding to 199 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 49,113 shares worth $9.41M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Pultegroup, an estimated $1.87M trimmed.

  • Aster Capital Management's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 49,113 shares worth $9.41M.
  • Aster Capital Management added most to Broadcom in Q4 2025, an estimated $15.8M increase.
  • Aster Capital Management's biggest Q4 2025 reduction was Pultegroup, cutting an estimated $1.87M.
  • Aster Capital Management fully exited Johnson & Johnson in Q4 2025, selling an estimated $4.18M.
  • Aster Capital Management's ten largest holdings make up 32% of its $228M portfolio in Q4 2025.
  • Aster Capital Management opened 557 new positions and closed 433 in Q4 2025.
  • Aster Capital Management's portfolio value rose 15% quarter-over-quarter to $228M.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.